Eight deals priced this week, raising a combined $740 million. Meal-kit unicorn Blue Apron led the pack along with two banks, four biotechs and an enterprise storage provider. The week also saw one SPAC IPO and one Reg A+ offering. Before this week, the...read more
Avenue Therapeutics, which is a Fortress Biotech spinoff developing an IV formulation of the opioid tramadol, raised $33 million by offering 5.5 million shares at $6, the midpoint of the $5 to $7 lowered range. Avenue Therapeutics plans to list on the Nasdaq...read more
Avenue Therapeutics, which is a Fortress Biotech spinoff developing an IV formulation of the opioid tramadol, lowered the proposed deal size for its upcoming IPO on Friday. The New York, NY-based company now plans to raise $30 million by offering 5 million...read more
There are three deals raising a total of $194 million on the calendar for the week ahead. Each deal is raising less than $100 million. The week’s two biotechs,...read more
US IPO Weekly Recap: Blue Apron breaks in a busy week for IPOs
Eight deals priced this week, raising a combined $740 million. Meal-kit unicorn Blue Apron led the pack along with two banks, four biotechs and an enterprise storage provider. The week also saw one SPAC IPO and one Reg A+ offering. Before this week, the...read more
Micro-cap opioid biotech Avenue Therapeutics prices IPO at $6, midpoint of the lowered range
Avenue Therapeutics, which is a Fortress Biotech spinoff developing an IV formulation of the opioid tramadol, raised $33 million by offering 5.5 million shares at $6, the midpoint of the $5 to $7 lowered range. Avenue Therapeutics plans to list on the Nasdaq...read more
Cutting the dosage: micro-cap opioid biotech Avenue Therapeutics slashes IPO range by 40%
Avenue Therapeutics, which is a Fortress Biotech spinoff developing an IV formulation of the opioid tramadol, lowered the proposed deal size for its upcoming IPO on Friday. The New York, NY-based company now plans to raise $30 million by offering 5 million...read more
US IPO Week Ahead: Billboards and biotechs with 3 small IPOs
There are three deals raising a total of $194 million on the calendar for the week ahead. Each deal is raising less than $100 million. The week’s two biotechs,...read more